The Janus-like Association between Proton Pump Inhibitors and Dementia

Early pharmacoepidemiological studies suggested that Proton Pump Inhibitors (PPIs) might increase the risk of Alzheimer’s Disease (AD) and non-AD related dementias. These findings were supported by preclinical studies, specifically stressing the proamyloidogenic and indirect anticholinergic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Papazoglou, Anna, Arshaad, Muhammad I., Henseler, Christina, Daubner, Johanna, Broich, Karl, Haenisch, Britta, Weiergräber, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778640/
https://www.ncbi.nlm.nih.gov/pubmed/34587884
http://dx.doi.org/10.2174/1567205018666210929144740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778640/
https://www.ncbi.nlm.nih.gov/pubmed/34587884
http://dx.doi.org/10.2174/1567205018666210929144740

Ejemplares similares